0001213900-22-001613.txt : 20220111 0001213900-22-001613.hdr.sgml : 20220111 20220111203027 ACCESSION NUMBER: 0001213900-22-001613 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIDRON NADAV CENTRAL INDEX KEY: 0001351779 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35813 FILM NUMBER: 22525254 MAIL ADDRESS: STREET 1: 142 W. 57TH ST. CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980376008 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-844-1164 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4/A 1 ownership.xml X0306 4/A 2022-01-03 2022-01-05 0 0001176309 ORAMED PHARMACEUTICALS INC. ORMP 0001351779 KIDRON NADAV 1185 AVENUE OF THE AMERICAS, THIRD FLOOR NEW YORK, NY 10036 1 1 0 0 President and CEO Common Stock 2022-01-03 4 A 0 150000 A 916481 D Common Stock 2022-01-03 4 F 0 48752 13.89 D 867729 D Common Stock 2022-01-03 4 A 0 63000 A 930729 D Stock Option (right to buy 13.89 2022-01-03 4 A 0 107000 0 A 2032-01-03 Common Stock 107000 107000 D Represents Common Stock granted by the Issuer that vested upon grant. Payment of tax liability by withholding securities incident to the 150,000 shares of Common Stock granted on January 3, 2022. Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 15,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Kidron, which reported that 950,729 shares of common stock are beneficially owned by him following the reported transactions. Mr. Kidron beneficially owned 930,729 shares of common stock following the reported transactions. The Stock Option will vest in 4 installments as follows: 26,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. /s/ Nadav Kidron 2022-01-11